DiamiR
Monmouth Junction
About DiamiR
DiamiR is mission is to build a leading molecular diagnostics company focused on developing minimally invasive solutions for early detection and monitoring of brain and synaptic health conditions, including mild cognitive impairment and Alzheimer’s disease, to enable earlier intervention and better planning of care.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.5M
- Funding stage: M&A
- Last round: Grant (Oct 2020)
- Website: diamirbio.com
- Phone: 917-678-0990
Industries & Categories
Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/diamir-43766 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.